Stomalox 400mg+400mg tablets chewable

Valsts: Armēnija

Valoda: angļu

Klimata pārmaiņas: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktīvā sastāvdaļa:

aluminium hydroxide, magnesium hydroxide

Pieejams no:

Arpimed LLC

ATĶ kods:

A02AD01

SNN (starptautisko nepatentēto nosaukumu):

aluminium hydroxide, magnesium hydroxide

Deva:

400mg+400mg

Zāļu forma:

tablets chewable

Vienības iepakojumā:

(30/5x6/) and (40/4x10/) blisters

Receptes veids:

OTC

Autorizācija statuss:

Registered

Autorizācija datums:

2015-12-25

Produkta apraksts

SUMMARY PRODUCT CHARACTERISTIC (SPC)
STOMALOX
CHEWABLE TABLETS BRAND NAME – Stomalox
INTERNATIONAL
NON-PROPERTY
NAME
–
Aluminum
hydroxide
/
Magnesium hydroxide
COMPOSITION
Each chewable tablet_ _contains:
_ACTIVE INGREDIENT: _Aluminum hydroxide 400 mg, Magnesium hydroxide
400 mg
_INACTIVE INGREDIENTS:_ maize starch, xylitol, sodium starch
glycolate, magnesium stearate, mint
flavor.
PHARMACEUTICAL FORM: Chewable Tablets GENERAL CHARACTERISTICS
_PHYSICAL AND CHEMICAL PROPERTIES_
_ _
White or white off flat cylindrical tablets with a few small patches
of yellow colour and specific
odor..
PHARMACOLOGICAL GROUP AND ATC CODE
Antacid;
A02AD01
PHARMACOLOGY
STOMALOX is a well-balanced combination of magnesium hydroxide and
aluminum hydroxide, which
ensures its high neutralizing capacity and cytoprotective effect.
Aluminum hydroxide inhibits the
secretion of pepsin, neutralizes hydrochloric acid forming aluminum
chloride, which turns to
alkaline aluminum salts in an alkaline environment. Magnesium
hydroxide also neutralizes the
hydrochloric acid, turning into magnesium chloride, which has a small
laxative action. Thus, the
counteract effect of aluminum hydroxide carries out counteracts the
effects of aluminum hydroxide,
which causes constipation.
Acid-neutralizing activity of 1 tablet of the preparation STOMALOX is
18.5
meq of the hydrochloric acid. Preparation has antacid, absorbent and
protective effect, soothes the
pain in the upper digestive tract for several hours.
PHARMACOKINETICS
The active ingredients of the preparation practically don't absorbe
from the gastrointestinal tract. INDICATIONS
Symptomatic treatment of increased gastric acidity conditions in
diseases:
- Acute gastritis,
- Chronic gastritis with increased secretory function in the
exacerbation phase,
- Gastroesophageal disease,
- Hiatus hernia,
- Gastroduodenitis,
- Stomach ulcers and duodenal ulcer (prevention and symptomatic
therapy),
Can be used in heartburn after errors in diet, after reception of
medications and alcohol abuse,
coffee, nicotine.